255 related articles for article (PubMed ID: 1398303)
1. Chronic lymphocytic leukemia coexisting with chronic myelomonocytic leukemia.
Ferrara F; Del Vecchio L; Antonolfi I; Mele G; Rametta V; Cimino R
Haematologica; 1992; 77(2):171-3. PubMed ID: 1398303
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric analysis of T and Tn epitopes on chronic lymphocytic leukemia cells.
Aller CT; Kucuk O; Springer GF; Gilman-Sachs A
Am J Hematol; 1996 May; 52(1):29-38. PubMed ID: 8638608
[TBL] [Abstract][Full Text] [Related]
3. Peroxidase-negative and myelomonocytic antigen-positive acute leukemia.
Okawa H; Nagasawa M; Morio T; Takase K; Tanaka K; Yata J; Dan K; Nomura T; Sakamaki H; Onozawa Y
Int J Hematol; 1992 Apr; 55(2):165-71. PubMed ID: 1324747
[TBL] [Abstract][Full Text] [Related]
4. [Significance and independence of the immunologic, histological, and clinical features as prognostic factors in chronic lymphatic leukemia].
Resegotti L; Levis A; Decrescenzo A; Ficara F; Pini M
Haematologica; 1989 Oct; 74(5 Suppl):368-79. PubMed ID: 2512221
[No Abstract] [Full Text] [Related]
5. Immunobiology of chronic lymphocytic leukemia.
Freedman AS
Hematol Oncol Clin North Am; 1990 Apr; 4(2):405-29. PubMed ID: 2182599
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F
Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
[TBL] [Abstract][Full Text] [Related]
8. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
Kusenda J; Babusíková O
Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
[TBL] [Abstract][Full Text] [Related]
9. [Presence of B cell clones in acute myelomonocytic leukemia].
Novoa V; Nuñez N; Cervellini M; Starosta A; Carballo OG
Medicina (B Aires); 2010; 70(2):163-5. PubMed ID: 20447900
[TBL] [Abstract][Full Text] [Related]
10. The clinical and laboratory approach to the CD5/CD10 negative B-cell chronic lymphoproliferative leukemias.
Hanson CA; Morice WG
Am J Hematol; 2008 May; 83(5):347-8. PubMed ID: 18383327
[No Abstract] [Full Text] [Related]
11. Intracellular and serum levels of aldolase activity in B chronic lymphocytic leukemia.
Musolino C; Alonci A; Allegra A; Di Cesare E; Orlando A; Grosso P; Buda G; Squadrito G
Int J Hematol; 1992 Dec; 56(3):213-7. PubMed ID: 1477333
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric analysis of monocytes as a tool for distinguishing chronic myelomonocytic leukemia from reactive monocytosis.
Xu Y; McKenna RW; Karandikar NJ; Pildain AJ; Kroft SH
Am J Clin Pathol; 2005 Nov; 124(5):799-806. PubMed ID: 16203279
[TBL] [Abstract][Full Text] [Related]
13. Correspondence re: Kaiserling E, Horny HP, Geerts M-L, Schmid U: Skin involvement in myelogenous leukemia: morphologic and immunophenotypic heterogeneity of skin infiltrates. Mod Pathol 7:771, 1994.
Orazi A
Mod Pathol; 1995 Apr; 8(3):340-1. PubMed ID: 7542388
[No Abstract] [Full Text] [Related]
14. Lymphoblastic transformation of chronic myelomonocytic leukemia in an infant.
Yamamoto M; Nakagawa M; Ichimura N; Ohtsuki F; Ohtsuka Y; Tsujino Y; Tanaka A; Kamiya T; Wada H
Am J Hematol; 1996 Jul; 52(3):212-4. PubMed ID: 8756090
[TBL] [Abstract][Full Text] [Related]
15. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia.
Ibrahim S; Jilani I; O'Brien S; Rogers A; Manshouri T; Giles F; Faderl S; Thomas D; Kantarjian H; Keating M; Albitar M
Cancer; 2003 Apr; 97(8):1914-9. PubMed ID: 12673718
[TBL] [Abstract][Full Text] [Related]
17. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
[TBL] [Abstract][Full Text] [Related]
18. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
[TBL] [Abstract][Full Text] [Related]
19. Immunological markers in a coexisting chronic lymphocytic leukemia and Hodgkin's disease.
Ojeda E; Gonzalez M; SanMiguel JF; Ramos F; Flores T; Borrasca AL
Haematologia (Budap); 1988; 21(3):163-7. PubMed ID: 3181819
[TBL] [Abstract][Full Text] [Related]
20. CD5+ chronic B-cell leukemia with features intermediate to chronic lymphocytic leukemia and hairy cell leukemia.
Aljurf M; Cornbleet PJ; Michel F
Hematol Pathol; 1994; 8(3):99-109. PubMed ID: 7527021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
